Aocnp (Advanced Oncology Certified Nurse
Practitioner) With Correct Actual Questions
And Correctly Well Defined Answers Latest
Already Graded A+ (2025/2026)
Advanced Oncology Nursing: Certification Exam Preparation
Advanced Oncology Certified Nurse Practitioner (AOCNP®) Comprehensive Assessment
1. A 52-year-old woman with a strong family history of early-onset breast and ovarian
cancer is seen for genetic risk assessment. She has no personal history of cancer. Which
feature of her family history most strongly warrants referral for hereditary cancer
syndrome evaluation?
A. A maternal aunt diagnosed with breast cancer at age 62
B. A paternal grandmother with ovarian cancer at age 70
C. A sister with triple-negative breast cancer at age 39
D. A mother with breast cancer at age 48 and a maternal uncle with pancreatic cancer at age
55
The correct answer is D. A family history suggestive of a hereditary breast and ovarian cancer
syndrome includes early-onset breast cancer, ovarian cancer, and associated malignancies such
as pancreatic and prostate cancer. The combination of breast cancer before age 50 and
pancreatic cancer in a close relative on the same side of the family meets criteria for further risk
assessment, such as BRCA1/2 testing or multigene panel testing. Options A and B describe later-
onset cancers that are less suggestive of a high-penetrance hereditary syndrome. Option C is
concerning for early-onset breast cancer, but the co-occurrence of pancreatic cancer in D
strengthens the hereditary pattern.
, 2. A 60-year-old man with a 45-pack-year smoking history presents for lung cancer
screening discussion. He is asymptomatic and has no prior history of cancer. According
to current United States Preventive Services Task Force recommendations, which
statement is most accurate regarding his eligibility for low-dose computed tomography
screening?
A. He is not eligible because he has no symptoms of lung cancer.
B. He is eligible if he is aged 50 to 80 years, has at least a 20-pack-year history, and currently
smokes or has quit within the past 15 years.
C. He is eligible only if he has a documented pulmonary nodule on prior chest radiography.
D. He should undergo annual chest radiography rather than low-dose computed tomography.
The correct answer is B. The USPSTF recommends annual low-dose CT screening for adults aged
50 to 80 years who have a 20-pack-year or greater smoking history and currently smoke or have
quit within the past 15 years. Screening is offered to asymptomatic individuals at risk, not only
those with symptoms. Chest radiography is not an accepted screening modality for lung cancer.
Option A reflects a misunderstanding of screening versus diagnostic testing, and option D
reflects an outdated or inappropriate screening method.
3. A 45-year-old woman with a BRCA1 pathogenic variant is considering risk-reducing
surgery. She has completed childbearing and asks about the impact of risk-reducing
salpingo-oophorectomy on her cancer risk. Which statement by the advanced practice
nurse is most accurate?
A. It eliminates the risk of breast cancer entirely.
B. It reduces ovarian cancer risk substantially but has no effect on breast cancer risk.
C. It reduces the risk of ovarian cancer by approximately 80% to 96% and also reduces breast
cancer risk when performed premenopausally.
D. It should be deferred until after age 60 because of surgical menopause risks.
The correct answer is C. Risk-reducing salpingo-oophorectomy in BRCA1/2 carriers substantially
reduces the risk of ovarian cancer and, when performed before menopause, is associated with a
reduction in breast cancer risk. It does not eliminate breast cancer risk entirely, so option A is
incorrect. Option B is inaccurate because premenopausal oophorectomy does confer breast
cancer risk reduction. Option D is inappropriate; guidelines generally recommend risk-reducing
salpingo-oophorectomy between ages 35 and 40 for BRCA1 carriers and between 40 and 45 for
BRCA2 carriers, or after completion of childbearing, rather than deferring to age 60.
4. A 38-year-old man with a new diagnosis of stage III colon cancer asks whether his
children should undergo genetic testing. His tumor testing demonstrates mismatch
, repair deficiency and microsatellite instability-high status. Which recommendation by
the oncology APRN is most appropriate?
A. Genetic testing is not indicated because his cancer is somatic in origin.
B. His children should undergo colonoscopy at age 50, which is the standard average-risk
screening age.
C. Referral for germline genetic evaluation is indicated because mismatch repair deficiency
and microsatellite instability-high tumor status may indicate Lynch syndrome.
D. Genetic testing should be offered only if he has a family history of colon cancer.
The correct answer is C. Mismatch repair deficiency and microsatellite instability-high tumor
status in colon cancer warrant evaluation for Lynch syndrome, particularly when diagnosed at a
young age. Germline testing can inform cascade testing for at-risk relatives and guide
surveillance recommendations. Option A is incorrect because somatic tumor testing does not
exclude a germline syndrome; in fact, abnormal tumor testing is a common trigger for germline
evaluation. Option B reflects average-risk screening and is inadequate for family members of a
potential Lynch syndrome kindred. Option D is incorrect because universal tumor screening and
germline evaluation can be indicated regardless of a documented family history.
5. A 55-year-old woman with newly diagnosed hormone receptor-positive, HER2-negative
metastatic breast cancer is being evaluated for treatment planning. Which biomarker
result would most directly influence the selection of endocrine therapy versus
chemotherapy in the absence of visceral crisis?
A. Tumor mutational burden
B. Programmed death-ligand 1 expression
C. Estrogen receptor and progesterone receptor expression
D. Microsatellite instability status
The correct answer is C. Estrogen receptor and progesterone receptor expression determine
eligibility for endocrine therapy, which is the preferred initial approach for hormone receptor-
positive metastatic breast cancer in the absence of visceral crisis. Tumor mutational burden,
programmed death-ligand 1 expression, and microsatellite instability status are relevant for
other therapeutic decisions, such as immunotherapy, but are not the primary determinants of
endocrine therapy selection in this scenario.
6. A 62-year-old man with non-small cell lung cancer is being considered for immune
checkpoint inhibitor therapy. Which patient characteristic should the oncology APRN
identify as a potential contraindication or reason for heightened caution?
A. A history of well-controlled hypertension
B. A prior splenectomy for trauma
, C. A history of autoimmune thyroiditis requiring thyroid replacement
D. A history of localized prostate cancer treated with prostatectomy
The correct answer is C. Pre-existing autoimmune disease, including autoimmune thyroiditis, is a
relative concern with immune checkpoint inhibitors because these agents can exacerbate
underlying autoimmunity. Patients with pre-existing autoimmune conditions require careful
multidisciplinary evaluation before treatment. Well-controlled hypertension, prior splenectomy
for trauma, and a history of treated localized prostate cancer are not absolute contraindications,
although each may warrant individualized assessment.
7. A 70-year-old woman with stage IV ovarian cancer has completed initial chemotherapy
and is now in clinical remission. She asks about surveillance strategy. Which
recommendation is most consistent with current guidelines?
A. Routine serum CA-125 testing every 3 months for 5 years and annual computed tomography
B. Annual physical examination alone
C. Surveillance with history, physical examination, and CA-125 testing as clinically indicated,
with imaging reserved for symptoms or rising markers
D. Immediate initiation of maintenance chemotherapy regardless of response
The correct answer is C. Surveillance for ovarian cancer after first-line therapy generally includes
history, physical examination, and CA-125 testing, with imaging and other evaluations prompted
by symptoms or abnormal findings. Routine imaging and prolonged intensive CA-125 monitoring
in asymptomatic patients are not universally recommended because they have not consistently
improved survival and may lead to unnecessary intervention. Maintenance therapy decisions
depend on the specific regimen and molecular profile, not the mere fact of remission.
8. A 58-year-old man with metastatic colorectal cancer is receiving palliative
chemotherapy. His goals-of-care discussion documents that he values quality of life and
wishes to avoid burdensome interventions. He develops a malignant bowel obstruction.
Which approach by the oncology APRN best aligns with his stated goals?
A. Recommend urgent surgery regardless of performance status
B. Evaluate for nonsurgical symptom management options, such as octreotide,
corticosteroids, and decompression, and clarify goals with the patient and family
C. Discontinue all care and transition to hospice without further assessment
D. Initiate total parenteral nutrition as the primary intervention
The correct answer is B. In a patient with advanced cancer and a malignant bowel obstruction
who prioritizes quality of life, a goals-concordant approach includes assessing whether
nonsurgical symptom management (e.g., octreotide, dexamethasone, nasogastric
decompression, and analgesics) can provide relief. Surgery may be appropriate in selected
Practitioner) With Correct Actual Questions
And Correctly Well Defined Answers Latest
Already Graded A+ (2025/2026)
Advanced Oncology Nursing: Certification Exam Preparation
Advanced Oncology Certified Nurse Practitioner (AOCNP®) Comprehensive Assessment
1. A 52-year-old woman with a strong family history of early-onset breast and ovarian
cancer is seen for genetic risk assessment. She has no personal history of cancer. Which
feature of her family history most strongly warrants referral for hereditary cancer
syndrome evaluation?
A. A maternal aunt diagnosed with breast cancer at age 62
B. A paternal grandmother with ovarian cancer at age 70
C. A sister with triple-negative breast cancer at age 39
D. A mother with breast cancer at age 48 and a maternal uncle with pancreatic cancer at age
55
The correct answer is D. A family history suggestive of a hereditary breast and ovarian cancer
syndrome includes early-onset breast cancer, ovarian cancer, and associated malignancies such
as pancreatic and prostate cancer. The combination of breast cancer before age 50 and
pancreatic cancer in a close relative on the same side of the family meets criteria for further risk
assessment, such as BRCA1/2 testing or multigene panel testing. Options A and B describe later-
onset cancers that are less suggestive of a high-penetrance hereditary syndrome. Option C is
concerning for early-onset breast cancer, but the co-occurrence of pancreatic cancer in D
strengthens the hereditary pattern.
, 2. A 60-year-old man with a 45-pack-year smoking history presents for lung cancer
screening discussion. He is asymptomatic and has no prior history of cancer. According
to current United States Preventive Services Task Force recommendations, which
statement is most accurate regarding his eligibility for low-dose computed tomography
screening?
A. He is not eligible because he has no symptoms of lung cancer.
B. He is eligible if he is aged 50 to 80 years, has at least a 20-pack-year history, and currently
smokes or has quit within the past 15 years.
C. He is eligible only if he has a documented pulmonary nodule on prior chest radiography.
D. He should undergo annual chest radiography rather than low-dose computed tomography.
The correct answer is B. The USPSTF recommends annual low-dose CT screening for adults aged
50 to 80 years who have a 20-pack-year or greater smoking history and currently smoke or have
quit within the past 15 years. Screening is offered to asymptomatic individuals at risk, not only
those with symptoms. Chest radiography is not an accepted screening modality for lung cancer.
Option A reflects a misunderstanding of screening versus diagnostic testing, and option D
reflects an outdated or inappropriate screening method.
3. A 45-year-old woman with a BRCA1 pathogenic variant is considering risk-reducing
surgery. She has completed childbearing and asks about the impact of risk-reducing
salpingo-oophorectomy on her cancer risk. Which statement by the advanced practice
nurse is most accurate?
A. It eliminates the risk of breast cancer entirely.
B. It reduces ovarian cancer risk substantially but has no effect on breast cancer risk.
C. It reduces the risk of ovarian cancer by approximately 80% to 96% and also reduces breast
cancer risk when performed premenopausally.
D. It should be deferred until after age 60 because of surgical menopause risks.
The correct answer is C. Risk-reducing salpingo-oophorectomy in BRCA1/2 carriers substantially
reduces the risk of ovarian cancer and, when performed before menopause, is associated with a
reduction in breast cancer risk. It does not eliminate breast cancer risk entirely, so option A is
incorrect. Option B is inaccurate because premenopausal oophorectomy does confer breast
cancer risk reduction. Option D is inappropriate; guidelines generally recommend risk-reducing
salpingo-oophorectomy between ages 35 and 40 for BRCA1 carriers and between 40 and 45 for
BRCA2 carriers, or after completion of childbearing, rather than deferring to age 60.
4. A 38-year-old man with a new diagnosis of stage III colon cancer asks whether his
children should undergo genetic testing. His tumor testing demonstrates mismatch
, repair deficiency and microsatellite instability-high status. Which recommendation by
the oncology APRN is most appropriate?
A. Genetic testing is not indicated because his cancer is somatic in origin.
B. His children should undergo colonoscopy at age 50, which is the standard average-risk
screening age.
C. Referral for germline genetic evaluation is indicated because mismatch repair deficiency
and microsatellite instability-high tumor status may indicate Lynch syndrome.
D. Genetic testing should be offered only if he has a family history of colon cancer.
The correct answer is C. Mismatch repair deficiency and microsatellite instability-high tumor
status in colon cancer warrant evaluation for Lynch syndrome, particularly when diagnosed at a
young age. Germline testing can inform cascade testing for at-risk relatives and guide
surveillance recommendations. Option A is incorrect because somatic tumor testing does not
exclude a germline syndrome; in fact, abnormal tumor testing is a common trigger for germline
evaluation. Option B reflects average-risk screening and is inadequate for family members of a
potential Lynch syndrome kindred. Option D is incorrect because universal tumor screening and
germline evaluation can be indicated regardless of a documented family history.
5. A 55-year-old woman with newly diagnosed hormone receptor-positive, HER2-negative
metastatic breast cancer is being evaluated for treatment planning. Which biomarker
result would most directly influence the selection of endocrine therapy versus
chemotherapy in the absence of visceral crisis?
A. Tumor mutational burden
B. Programmed death-ligand 1 expression
C. Estrogen receptor and progesterone receptor expression
D. Microsatellite instability status
The correct answer is C. Estrogen receptor and progesterone receptor expression determine
eligibility for endocrine therapy, which is the preferred initial approach for hormone receptor-
positive metastatic breast cancer in the absence of visceral crisis. Tumor mutational burden,
programmed death-ligand 1 expression, and microsatellite instability status are relevant for
other therapeutic decisions, such as immunotherapy, but are not the primary determinants of
endocrine therapy selection in this scenario.
6. A 62-year-old man with non-small cell lung cancer is being considered for immune
checkpoint inhibitor therapy. Which patient characteristic should the oncology APRN
identify as a potential contraindication or reason for heightened caution?
A. A history of well-controlled hypertension
B. A prior splenectomy for trauma
, C. A history of autoimmune thyroiditis requiring thyroid replacement
D. A history of localized prostate cancer treated with prostatectomy
The correct answer is C. Pre-existing autoimmune disease, including autoimmune thyroiditis, is a
relative concern with immune checkpoint inhibitors because these agents can exacerbate
underlying autoimmunity. Patients with pre-existing autoimmune conditions require careful
multidisciplinary evaluation before treatment. Well-controlled hypertension, prior splenectomy
for trauma, and a history of treated localized prostate cancer are not absolute contraindications,
although each may warrant individualized assessment.
7. A 70-year-old woman with stage IV ovarian cancer has completed initial chemotherapy
and is now in clinical remission. She asks about surveillance strategy. Which
recommendation is most consistent with current guidelines?
A. Routine serum CA-125 testing every 3 months for 5 years and annual computed tomography
B. Annual physical examination alone
C. Surveillance with history, physical examination, and CA-125 testing as clinically indicated,
with imaging reserved for symptoms or rising markers
D. Immediate initiation of maintenance chemotherapy regardless of response
The correct answer is C. Surveillance for ovarian cancer after first-line therapy generally includes
history, physical examination, and CA-125 testing, with imaging and other evaluations prompted
by symptoms or abnormal findings. Routine imaging and prolonged intensive CA-125 monitoring
in asymptomatic patients are not universally recommended because they have not consistently
improved survival and may lead to unnecessary intervention. Maintenance therapy decisions
depend on the specific regimen and molecular profile, not the mere fact of remission.
8. A 58-year-old man with metastatic colorectal cancer is receiving palliative
chemotherapy. His goals-of-care discussion documents that he values quality of life and
wishes to avoid burdensome interventions. He develops a malignant bowel obstruction.
Which approach by the oncology APRN best aligns with his stated goals?
A. Recommend urgent surgery regardless of performance status
B. Evaluate for nonsurgical symptom management options, such as octreotide,
corticosteroids, and decompression, and clarify goals with the patient and family
C. Discontinue all care and transition to hospice without further assessment
D. Initiate total parenteral nutrition as the primary intervention
The correct answer is B. In a patient with advanced cancer and a malignant bowel obstruction
who prioritizes quality of life, a goals-concordant approach includes assessing whether
nonsurgical symptom management (e.g., octreotide, dexamethasone, nasogastric
decompression, and analgesics) can provide relief. Surgery may be appropriate in selected
